Higher doses might mean more frequent stomach issues
First, the FDAs resolution of the semaglutide and tirzepatide shortages in mid-2024 ended the broad compounding allowance under section 503A, narrowing the legal path for compounded versions to patients with documented medical need (specific dose unavailable, sensitivity to a commercial inactive ingredient)
Heres a post about mindful eating on GLP-1 that helped me trust those signals again The 7-Day Plan People Use When Appetite Is Tiny and Nothing Sounds Good After a while, I started falling into a rhythm
You're more likely to benefit if: You feel heavy specifically after higher-fat meals (lipase may help with fat digestion) You get gas or bloating after dairy (lactase may help if lactose is the trigger) You notice predictable bloating after beans, certain vegetables, or starch-heavy meals (some blends include enzymes aimed at complex carbs) You can eat a small, protein-forward meal but feel uncomfortable when the protein is denser (protease support may help) A GLP-1-friendly way to interpret "success" is modest: less post-meal pressure, less burping, less gassiness, and a smoother digestion experience
Even though lyophilized peptides tolerate room temperature for shipping, they begin degrading more rapidly outside controlled conditions
Naturally occurring compound
